Zoetis Inc.
ZTSNYSEHealthcare● Active
$78.26
$-1.18(-1.49%)
Market Cap$32.8B
P/E Ratio—
52W High$171.52
52W Low$72.38
Zoetis Inc.（ZTS）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ZTS · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $9.47B | $9.26B | $8.54B | $8.08B | $7.78B |
| Cost of Revenue | $2.79B | $2.86B | $2.71B | $2.60B | $2.46B |
| Gross Profit | $6.67B | $6.40B | $5.83B | $5.48B | $5.31B |
| Gross Margin %(computed) | 70.49% | 69.10% | 68.28% | 67.77% | 68.31% |
| Operating Expenses | |||||
| R&D Expenses | $0.70B | $0.69B | $0.61B | $0.54B | $0.51B |
| G&A Expenses | $0.00B | $2.02B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $3.08B | $3.00B | $2.77B | $2.55B | $2.51B |
| Operating Income | $3.60B | $3.39B | $3.07B | $2.93B | $2.80B |
| Operating Margin %(computed) | 38.00% | 36.65% | 35.92% | 36.24% | 36.05% |
| Interest Income | $0.09B | $0.11B | $0.10B | $0.05B | $0.01B |
| Interest Expense | $0.24B | $0.24B | $0.26B | $0.24B | $0.24B |
| Income Before Tax | $3.36B | $3.13B | $2.94B | $2.66B | $2.49B |
| Income Tax Expense | $0.69B | $0.64B | $0.60B | $0.55B | $0.45B |
| Net Income | $2.67B | $2.49B | $2.34B | $2.11B | $2.04B |
| Net Margin %(computed) | 28.23% | 26.86% | 27.43% | 26.16% | 26.20% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $6.03 | $5.47 | $5.08 | $4.51 | $4.29 |
| Wtd Avg Shares | 0.44B | 0.45B | 0.46B | 0.47B | 0.47B |
| EBITDA | $4.07B | $3.87B | $3.69B | $3.36B | $3.17B |
| EBITDA Margin %(computed) | 42.98% | 41.83% | 43.13% | 41.56% | 40.79% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Zoetis Inc.
关于Zoetis Inc.（ZTS）损益表
Zoetis Inc.（ZTS）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，ZTS实现营收$9.47B，毛利润$6.67B（毛利率70.49%），净利润$2.67B（净利率28.23%）。
常见问题
ZTS · 4 问Zoetis Inc.（ZTS）2025财年营收为$9.47B，同比up2.3%。
ZTS revenueZTS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08